26 October 2020

The research group led by researcher and general practitioner Erik Bischoff has received a ZonMw grant from the call ´Goed Gebruik Geneesmiddelen´ for study cardiovascular risk management. 

The grant of over 680,000 euros is intended for research into cardiovascular risk management in people with antipsychotic drugs in general practice. Special is that in addition to this subsidy, the study also receives an in-kind contribution of 130,000 euros from the Arnhem care group Onze Huisartsen BV where the research takes place.
Erik Bischoff: 'The care group has developed a wonderful intervention in which general practitioners, psychiatrists, pharmacists and practice nurses work closely with patients with antipsychotics to reduce unnecessary medication use and reduce the increased risk of cardiovascular disease. In our TACTIC project we will first test this intervention on a small scale and then evaluate its effects and costs in a large experiment'.

Promotion project

The research forms the PhD trajectory for ELG framework doctor for cardiovascular diseases Kirsti Jakobs who played an important role in the development of the intervention. Her earlier research showed that people with severe mental illness (EPA) are estimated to die between eight and twenty years earlier than the general population, especially from cardiovascular diseases.

This ELG study, published in BMC Family Practice, shows that this group is only screened in 8.5%. Only in the case of diabetes mellitus does the annual screening reach 68.4%. People with EPA benefit from a customized cardiovascular risk management (CVRM), but are not yet mentioned in the standard CVRM of the Dutch Society of General Practitioners. Researcher and ELG PhD candidate Kirsti Jakobs: 'Our research also shows that in 68.3% of antipsychotic users no suitable EPA diagnosis was registered in the GP information system. This could be an indication that GPs often prescribe antipsychotics off-label, lack diagnostic information or register the wrong code. GPs are in a key position to proactively invite this vulnerable group to CVRM. It is recommended to be vigilant when prescribing antipsychotics off-label or not properly documented'.

 

Related news items


Radboudumc research most lungs recover well after COVID-19

26 November 2020

In severe COVID-19 patients the lung tissue recovers well in most cases. This is shown in research by the Radboudumc, published in Clinical Infectious Diseases. Striking conclusion: patients who were referred by the general practitioner recover worse than ICU patients.

read more

Marianne Boenink has been appointed professor in Ethics of Healthcare

26 November 2020

Health scientist and philosopher Marianne Boenink has been appointed professor in Ethics of Healthcare at the Radboud University/ Radboudumc, as of 1 August 2020.

read more

Patrick Jeurissen member Scientific Advisory Board for European Commission on health care policy in pandemics

26 November 2020

Patrick Jeurissen, Professor of Affordability of Care, has been appointed as a member of the Scientific Advisory Board for the Pan-European Commission on Health and Sustainable Development. This committee will study healthcare policy in the light of pandemics in the coming year.

read more

Erik van der Heijden received The Distinguished WABIP Regent Award

26 November 2020

The 21st World Conference on Bronchoscopy and Intervention Pulmonology (WCBIP) is currently taking place in Shanghai. This is organized by the WABIP. Erik van der Heijden, member of the scientific organizing committee, received the prize ‘The Distinguished WABIP Regent Award'.

read more

Radboudumc researchers nominated for VIVA400

19 November 2020

In the annual VIVA400 list, Radboudumc researchers Cindy Nabuurs, Nicole van Gelder and Mieke Meulendijks are nominated. They have the chance to be awarded in the category Knappe Koppen. Please vote before 1 December.

read more

Online recruitment of study participants

19 November 2020

On 17 November 2020, more than 70 colleagues discussed 'Online recruitment of study participants’ in a webinar organized by RIHS. This webinar was the first chapter of the RIHS digital health research series.

read more